Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

MDGL Madrigal Pharmaceuticals Inc

314,80

1,69 (0,54%)

Zuletzt aktualisiert: 18:48:53

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Madrigal Pharmaceuticals Charts.

News Madrigal Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 22 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 1 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Madrigal Pharmaceuticals Inc News-Artikel

Inspirit Energy

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen